107 related articles for article (PubMed ID: 8740972)
1. Design and evaluation of small peptides mapping the exposed surface of IL-8.
Thompson SK; Veber DF; Jurewicz AJ; Peishoff CE; Lee JM; White JR
Int J Pept Protein Res; 1996 Mar; 47(3):214-8. PubMed ID: 8740972
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil activation by monomeric interleukin-8.
Rajarathnam K; Sykes BD; Kay CM; Dewald B; Geiser T; Baggiolini M; Clark-Lewis I
Science; 1994 Apr; 264(5155):90-2. PubMed ID: 8140420
[TBL] [Abstract][Full Text] [Related]
3. Mutagenesis studies of interleukin-8. Identification of a second epitope involved in receptor binding.
Williams G; Borkakoti N; Bottomley GA; Cowan I; Fallowfield AG; Jones PS; Kirtland SJ; Price GJ; Price L
J Biol Chem; 1996 Apr; 271(16):9579-86. PubMed ID: 8621632
[TBL] [Abstract][Full Text] [Related]
4. A molecular switch of chemokine receptor selectivity. Chemical modification of the interleukin-8 Leu25 --> Cys mutant.
Lusti-Narasimhan M; Chollet A; Power CA; Allet B; Proudfoot AE; Wells TN
J Biol Chem; 1996 Feb; 271(6):3148-53. PubMed ID: 8621714
[TBL] [Abstract][Full Text] [Related]
5. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket.
Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P
J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516
[TBL] [Abstract][Full Text] [Related]
6. Structure of a CXC chemokine-receptor fragment in complex with interleukin-8.
Skelton NJ; Quan C; Reilly D; Lowman H
Structure; 1999 Feb; 7(2):157-68. PubMed ID: 10368283
[TBL] [Abstract][Full Text] [Related]
7. Structure and activity of a chimeric interleukin-8-melanoma-growth-stimulatory-activity protein.
Sticht H; Auer M; Schmitt B; Besemer J; Horcher M; Kirsch T; Lindley IJ; Rösch P
Eur J Biochem; 1996 Jan; 235(1-2):26-35. PubMed ID: 8631339
[TBL] [Abstract][Full Text] [Related]
8. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling.
Zhong W; Zen Q; Tebo J; Schlottmann K; Coggeshall M; Mortensen RF
J Immunol; 1998 Sep; 161(5):2533-40. PubMed ID: 9725253
[TBL] [Abstract][Full Text] [Related]
9. Monomeric variants of IL-8: effects of side chain substitutions and solution conditions upon dimer formation.
Lowman HB; Fairbrother WJ; Slagle PH; Kabakoff R; Liu J; Shire S; Hébert CA
Protein Sci; 1997 Mar; 6(3):598-608. PubMed ID: 9070442
[TBL] [Abstract][Full Text] [Related]
10. A synthetic peptide which specifically inhibits heat-treated interleukin-8 binding and chemotaxis for neutrophils.
Miller EJ; Kurdowska A; Nagao S; Carr FK; Hayashi S; Atkinson MA; Cohen AB
Agents Actions; 1993 Nov; 40(3-4):200-8. PubMed ID: 8023744
[TBL] [Abstract][Full Text] [Related]
11. Mapping the binding surface of interleukin-8 complexed with an N-terminal fragment of the type 1 human interleukin-8 receptor.
Clubb RT; Omichinski JG; Clore GM; Gronenborn AM
FEBS Lett; 1994 Jan; 338(1):93-7. PubMed ID: 8307164
[TBL] [Abstract][Full Text] [Related]
12. Physical association of Gi2alpha with interleukin-8 receptors.
Damaj BB; McColl SR; Mahana W; Crouch MF; Naccache PH
J Biol Chem; 1996 May; 271(22):12783-9. PubMed ID: 8662698
[TBL] [Abstract][Full Text] [Related]
13. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
Jerva LF; Sullivan G; Lolis E
Protein Sci; 1997 Aug; 6(8):1643-52. PubMed ID: 9260277
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2.
Wolf M; Delgado MB; Jones SA; Dewald B; Clark-Lewis I; Baggiolini M
Eur J Immunol; 1998 Jan; 28(1):164-70. PubMed ID: 9485196
[TBL] [Abstract][Full Text] [Related]
15. Molecular approaches to structure-function analysis of interleukin-8.
Fairbrother WJ; Lowman HB
Methods Enzymol; 1997; 287():45-58. PubMed ID: 9330314
[No Abstract] [Full Text] [Related]
16. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
Gerber N; Lowman H; Artis DR; Eigenbrot C
Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities.
Clark-Lewis I; Schumacher C; Baggiolini M; Moser B
J Biol Chem; 1991 Dec; 266(34):23128-34. PubMed ID: 1744111
[TBL] [Abstract][Full Text] [Related]
18. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
[TBL] [Abstract][Full Text] [Related]
19. IL-8 single-chain homodimers and heterodimers: interactions with chemokine receptors CXCR1, CXCR2, and DARC.
Leong SR; Lowman HB; Liu J; Shire S; Deforge LE; Gillece-Castro BL; McDowell R; Hébert CA
Protein Sci; 1997 Mar; 6(3):609-17. PubMed ID: 9070443
[TBL] [Abstract][Full Text] [Related]
20. IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors.
Hammond ME; Lapointe GR; Feucht PH; Hilt S; Gallegos CA; Gordon CA; Giedlin MA; Mullenbach G; Tekamp-Olson P
J Immunol; 1995 Aug; 155(3):1428-33. PubMed ID: 7636208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]